News and Announcements
Property investment tool TUDI featured in Yahoo! Finance
- Published September 18, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Highlights
- New technology TUDI is assisting investors by providing another tool to research where and when is best to invest.
- The property investment solution highlights where to buy by identifying suburbs with potential to outperform the market, but also indicates the best time to buy and sell.
- Since its inception in 2017, TUDI’s virtual portfolio has seen an overall ROI of 33%, outperforming the national price index.
This September 2019, TUDI has featured in Yahoo! Finance as their new technology is assisting investors by providing another tool to research when and where is best to invest. It is helping to provide investors with suburbs of interest to monitor as potential investing hot spots.
Since its inception in 2017, TUDI’s virtual portfolio has seen an overall ROI of 33%. Even its co-founders are cashing in on its success. Co-founders Julien Mougenot and Joseph Amoia purchased property in Moranbah in 2017 via information provided by TUDI. Fast forward to 2019 and the property has grown in value by 56% and the algorithm indicating it is a good time to sell.
The tool works off the simple premise of supply and demand, focusing on five key metrics including supply and demand, seller confidence and rental yield. It highlights where to buy by identifying suburbs with potential to outperform the market, but also indicates the best time to buy and sell.
Register your interest in TUDI below to keep up-to-date.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
